secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001493152-24-042071
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq delisting determination for missing filing deadlines
--------------------------------------------------------------------------------

- Nasdaq notified company on Oct 16, 2024 that it failed to file Form 10-K for 2023 and Forms 10-Q for Q1 and Q2 2024.
- Exception granted until Oct 14, 2024 was not met; company has not filed the required reports.
- Company will appeal the Staff determination to a Nasdaq Hearings Panel under Rule 5800 Series.
- Ticker OCEA and OCEAW remain listed pending appeal; outcome uncertain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224042071/0001493152-24-042071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224042071/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer